Skip to main content
. 2023 May 4;2023(5):CD013798. doi: 10.1002/14651858.CD013798.pub2

3. NMA results for OS (IMDC favourable risk group).

Results of network meta‐analysis for outcome overall survival (IMDC favourable risk group). Treatments are ordered by P‐Score (descending). Only subnetworks with >1 designs. Upper triangle: direct estimate. Lower triangle: network estimate.
Subnet 1
No. of studies: 5. No. of pairwise comparisons: 5. No. of treatments: 6. No. of designs: 5
Heterogeneity/Inconsistency: Q = 0, df = 0, P = n.a.; I²=n.a., Tau² = n.a.
Treatment Effects + 95%‐CIs (Hazard ratios, random‐effects model):
AVE+AXI . . . 0.66 [0.36, 1.22] .
0.71 [0.34, 1.48] NIV+IPI . . 0.93 [0.62, 1.40] .
0.70 [0.27, 1.80] 0.99 [0.43, 2.25] NIV+CAB . 0.94 [0.46, 1.92] .
0.65 [0.24, 1.77] 0.92 [0.38, 2.22] 0.93 [0.32, 2.68] LEN+EVE 1.01 [0.46, 2.20] .
0.66 [0.36, 1.22] 0.93 [0.62, 1.40] 0.94 [0.46, 1.92] 1.01 [0.46, 2.20] SUN 0.87 [0.42, 1.82]
0.57 [0.22, 1.50] 0.81 [0.35, 1.88] 0.82 [0.29, 2.28] 0.88 [0.30, 2.57] 0.87 [0.42, 1.82] LEN+PEM